0 Commentaires
0 Parts
169 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Revealed: Major Players Commanding a Significant Share of the US Idiopathic Pulmonary Fibrosis Treatment MarketRecent analysis unveils the competitive dynamics shaping the US idiopathic pulmonary fibrosis treatment market share, which is witnessing a substantial transformation as new therapies emerge. With a projected market size of $1.67 billion by 2035, leading players are establishing their positions in this growing landscape. The market is characterized by significant contributions from established...0 Commentaires 0 Parts 213 Vue 0 Aperçu
-
Global Demand Analysis of the Black Lung Disease MarketTechnological progress in pulmonary diagnostics is accelerating treatment adoption rates.Early intervention models are becoming a key focus in occupational disease management.These advancements are driving sustained demand for therapeutic solutions. The Black Lung Disease Market is progressing steadily as occupational respiratory care gains policy focus and clinical investment. Rising case...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Global Pirfenidone Tablets Market to Reach USD 2.08 Billion by 2034 Amid Rising IPF CasesAccording to a new report from Intel Market Research, the global Pirfenidone Tablets market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.08 billion by 2034, growing at a strong CAGR of 7.8% during the forecast period (2026–2034). This growth is driven by increasing prevalence of idiopathic pulmonary fibrosis (IPF), expanding geriatric population, and improved...0 Commentaires 0 Parts 4KB Vue 0 Aperçu